期刊
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
卷 292, 期 2, 页码 629-635出版社
SPRINGER
DOI: 10.1007/s10967-011-1499-7
关键词
Paroxetine; I-125; Chloramine-T; Lung perfusion scan
Paroxetine (a selective serotonin reuptake inhibitor) was successfully labeled with I-125 via direct electrophilic substitution reaction at ambient temperature. The reaction parameters studied were paroxetine amount, CAT amount, pH of the reaction mixture, reaction temperature, reaction time and in vitro stability of I-125-paroxetine. I-125-paroxetine was obtained with a maximum labeling yield of 94 +/- 0.23% and in vitro stability up to 24 h. Biodistribution studies showed that maximum in vivo uptake of I-125-paroxetine in lungs was 27.89 +/- 1.03% injected activity/g tissue at 15 min post-injection and retention in lungs remained high up to 1 h, whereas the clearance from mice appeared to proceed mainly via the hepatobiliary pathway. I-125-paroxetine is not a blood product and so it is more safe than the currently available Tc-99m-macroaggregated albumin (Tc-99m-MAA), and its lung uptake is higher than that of the recently discovered Tc-99m(CO)(5)I and Tc-99m-DHPM. As a conclusion, radioiodinated paroxetine could be used as a novel radiopharmaceutical for lung perfusion scan safer than the currently available Tc-99m-MAA and more potential than the recently discovered Tc-99m(CO)(5)I and Tc-99m-DHPM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据